Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess the performance of medtronic¿s pacific plus pta balloon catheter.
Survey results received for an interventional cardiologist with 30 years¿ experience.
The respondent has been using medtronic¿s pacific plus pta balloon catheter since (b)(6) 2019.
Overall, the respondent has used medtronic¿s pacific plus pta balloon catheter in a total of 17 procedures since beginning to use the system.
Of these procedures, the devices were used for dilatation of stenoses in patients with obstructive disease in iliac arteries (4), femoral arteries (2), iliofemoral arteries (8), infrapopliteal arteries (2) and renal arteries (1).
All of these procedures were carried out in the past 12 months.
The respondent has not used medtronic's pacific plus pta balloon catheter in any other anatomical locations other than those described above.
The respondent reports complications of balloon rupture associated specifically with dilation.
The balloon rupture event was deemed as being device related and considered as being not at all concerning as it was expected as the lesion was severely calcified.
|